z-logo
open-access-imgOpen Access
Effects of Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Treatment on Glucose Metabolism and Fat Distribution in Human Immunodeficiency Virus-Infected Patients with Abdominal Obesity and Insulin Resistance
Author(s) -
Madhu N. Rao,
Kathleen Mulligan,
Viva Tai,
Michael Wen,
Artem Dyachenko,
Melissa E. Weinberg,
Xiaojuan Li,
Thomas Lang,
Carl Grünfeld,
JeanMarc Schwarz,
Morris Schambelan
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-2502
Subject(s) - insulin resistance , medicine , endocrinology , abdominal obesity , insulin like growth factor , insulin , human immunodeficiency virus (hiv) , obesity , abdominal fat , metabolism , carbohydrate metabolism , growth factor , distribution (mathematics) , biology , virology , metabolic syndrome , receptor , mathematical analysis , mathematics
HIV-infected patients on antiretroviral therapy are at increased risk for excess visceral adiposity and insulin resistance. Treatment with GH decreases visceral adiposity but worsens glucose metabolism. IGF-I, which mediates many of the effects of GH, improves insulin sensitivity in HIV-negative individuals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom